New global map shows difficult-to-treat malaria strain remains prevalent in Asia, Latin America

NewsGuard 100/100 Score

"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes (Sinha, 12/5). The researchers from Britain's Oxford University mapped the Plasmodium vivax malaria parasite, "which is often recurring and can be deadly," and found it is "endemic in substantial parts of the world," particularly in Asia and Latin America, Reuters writes (Kelland, 12/5).

"'This map helps us understand just how difficult it is going to be to eradicate malaria,' said Peter Gething of the ... Malaria Atlas Project (MAP) team," adding, "Unfortunately, the tools for fighting this type of malaria range from ineffective to non-existent," an ASTMH press release states (12/5). "While not as deadly as the Plasmodium falciparum malaria parasite found in Africa, vivax is more common throughout the world, with an estimated 2.85 billion people at risk of infection, the researchers report," according to UPI.com (12/5).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pioneering study launched to examine how the immune system responds to repeated malaria infections